CIK 0001703057 · Large accelerated filer
AbCellera Biologics Inc.
Sign in to watch- Ticker
- ABCL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- operating
- Phone
- (604) 559-9005
- Business address
- 150 W 4TH AVENUE, VANCOUVER, British Columbia, Canada, V5Y 1G6
- 4 Open-market sale Chief Financial Officer sold 1,200,000 shares at $25.50 ($30,600,000)
- 4 Option exercise Chief Legal Officer acquired 1,000,000 shares (option exercise)
- 4 Option exercise Chief Financial Officer acquired 1,200,000 shares (option exercise)
- 8-K/A Event Results of operations · Regulation FD disclosure
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Regulation FD disclosure
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 4 Option exercise Chief Technology Officer acquired 1,000,000 shares (option exercise)
- 8-K Event Other events
- 10-K Report Annual Report
- 8-K Event Results of operations · Regulation FD disclosure
- 8-K Event Other events
- SC 13G Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- 3 Insider Initial Statement of Ownership
- SC 13D Stake Beneficial Ownership Report
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
Page 14 of 17 · 325 filings